AAM CEO ‘Not Fully Aligned With Biden Administration On Pay-For-Delay Ban’
Dan Leonard Talks Domestic Manufacturing, Patent Expiries And Medicare Modernization
In an exclusive interview with Generics Bulletin, US Association for Accessible Medicines CEO Dan Leonard has expressed concerns over the blanket change to patent settlements introduced by Joe Biden’s recent executive order. Furthermore, Leonard expects to see a “robust decade” for generic drugs, biosimilars and complex generics as many major brands are set to lose their exclusivity.
